GRNs showed that TBX5 dosage is critical for maintaining cardiac network stability and pointed out potential genetic interactions disrupted in TBX5-dependent congenital heart defects (CHDs), such as with MEF2C. This evidence concerns the gene TBX5 and congenital heart disease.